Skip to content

C.E Pharma

Active
Private limited companyfounded 2022active for 3 yearsRansfortstraat 87, 1080 Sint-Jans-Molenbeek, BelgiumKBO/BCE: BE 0793.409.817
Summary

The computed 12-month bankruptcy probability of C.E Pharma is 3.1% (moderate). The 2025 annual accounts show negative equity (-€46,167) and a net result of -€17,197. Equity is shrinking by about 69% per year across the filed financial years. Its solvency ranks better than 17% of 22,195 sector peers (NACE 47, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisWatch ReportCompare
C.E PharmaActiveChecked score 49/100
Risk analysis ReportCompare

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

We would like to set cookies. That happens only with your consent. What we measure